The firm, founded in 2003 and based in Kalamazoo, Michigan, aims to provide investors with superior financial returns by making equity investments in innovative life sciences companies with sustainable and outstanding growth potential. Apjohn Ventures Fund focuses on companies operating in the life science, pharmaceutical, medical device, diagnostic, healthcare service, and biotech sectors, and prefers to invest in early-stage companies located in the Midwest region of the United States.